Wnt-3a, Wnt-5a and conditioned medium from prostate cancer cells induced osteoblast differentiation in-vitro and pretreatment of prostate cancer cells with DKK1 diminished osteoblast differentiation. Here, WNT5A is linked to prostate cancer.